Francesca De Paolis

Istituto di Farmacologia Traslazionale — Italy

Medicine · Health Sciences

8h-index200citations17works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(4), T-cell and B-cell Immunology(3), Muscle Physiology and Disorders(3), Pneumonia and Respiratory Infections(3), 3D Printing in Biomedical Research(3)

Publications17 total

The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity
Experimental Hematology and Oncology·2025· 2 citedOpen Access
The CD64/CD28/CD3 ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity
2024Open Access
Long-term longitudinal study on swine VML model
Biology Direct·2023· 6 citedOpen Access
3D bioprinting directly affects proteomic signature and myogenic maturation in muscle pericytes-derived human myo-substitute
2023Open Access
Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases
Mechanisms of Ageing and Development·2023· 16 citedOpen Access
A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering
Biofabrication·2023· 61 citedOpen Access
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
Life Science Alliance·2022· 4 citedOpen Access
Dystrophic Muscle Affects Motoneuron Axon Outgrowth and NMJ Assembly
Advanced Materials Technologies·2022· 16 citedOpen Access
Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and Treatment
2021Open Access
Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold
Bioorganic & Medicinal Chemistry Letters·2013· 32 citedOpen Access
Abstract 1012: Pan HDACs inhibitor ST3595 targets PARP activity and has curative effect in breast BRCA-deficient model when combined with cisplatin treatment.
Cancer Research·2013
Mediation: Geography and Institutions
2012
Use of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection
European Journal of Clinical Microbiology & Infectious Diseases·2010· 14 citedOpen Access
Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library
Microbes and Infection·2008· 21 cited
Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display
Journal of Virological Methods·2008· 15 cited
Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae
BMC Microbiology·2007· 13 citedOpen Access
[Bacterial enzymatic activity in the oral cavity].
PubMed·1989

Frequent Co-authors

Sara Caratelli(5), Giuseppe Sconocchia(5), Valeriana Cesarini(5), Claudia Fuoco(4), Sergio Bernardini(4), Jacopo Baldi(4), Stefano Cannata(4), Stefano Testa(4), Cesare Gargioli(4), Elisa Beghetto(4), Giulia Lanzilli(4), Domenico Alessandro Silvestris(4), Roberto Arriga(4), Gabriele Toietta(4), Silvia Baldari(4), Tommaso Sconocchia(4), Giulio C. Spagnoli(4), Ersilia Fornetti(3), R. Biagini(3), Francesca Montagnani(3)